DRUG · Company research
Bright Minds Biosciences Inc. Common Stock (DRUG): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
23records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Trump Bought Millions in Drug Stocks Before Medicare Change—Democrat Report - Newsweek | Trump Bought Millions in Drug Stocks Before Medicare Change—Democrat Report Newsweek | View source ↗ | Newsweek | Oct 16, 2026 | neutral | 0 | 0.6 |
| Novartis Scraps Another Drug Study. Why the Stock Is Holding Steady. - Barron's | Novartis Scraps Another Drug Study. Why the Stock Is Holding Steady. Barron's | View source ↗ | Barron's | Oct 16, 2026 | neutral | 0 | 0.6 |
| Trump Pharma Stocks Surge Amid Medicare Exemption Report - Hoodline | Trump Pharma Stocks Surge Amid Medicare Exemption Report Hoodline | View source ↗ | Hoodline | Oct 16, 2026 | neutral | 0 | 0.6 |
| Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate - Utah Business | Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate Utah Business | View source ↗ | Utah Business | Oct 15, 2026 | neutral | 0 | 0.6 |
| Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 6.6% - Here's Why - MarketBeat | Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 6.6% - Here's Why MarketBeat | View source ↗ | MarketBeat | Oct 15, 2026 | neutral | 0 | 0.6 |
| Vanda Pharmaceuticals stock falls after anxiety drug trial fails - Yahoo Finance | Vanda Pharmaceuticals stock falls after anxiety drug trial fails Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Regulators Say Shkreli Violated Drug Stock Trading Ban | The Wall Street Journal - newspaper - Magzter | Regulators Say Shkreli Violated Drug Stock Trading Ban | The Wall Street Journal - newspaper Magzter | View source ↗ | Magzter | Oct 14, 2026 | neutral | 0 | 0.6 |
| FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks - WSJ | FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks WSJ | View source ↗ | WSJ | Oct 13, 2026 | neutral | 0 | 0.6 |
| FTC Says Martin Shkreli ‘Flagrantly’ Violated Lifetime Pharma Ban With Drug Stock Trades - Benzinga | FTC Says Martin Shkreli ‘Flagrantly’ Violated Lifetime Pharma Ban With Drug Stock Trades Benzinga | View source ↗ | Benzinga | Oct 13, 2026 | neutral | 0 | 0.6 |
| Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock? - The Motley Fool | Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock? The Motley Fool | View source ↗ | The Motley Fool | Oct 10, 2026 | neutral | 0 | 0.6 |
| 3 Diabetes And Obesity Drug Stocks Riding The GLP 1 Demand Boom - Simply Wall Street | 3 Diabetes And Obesity Drug Stocks Riding The GLP 1 Demand Boom Simply Wall Street | View source ↗ | Simply Wall Street | Oct 10, 2026 | neutral | 0 | 0.6 |
| 4 CNS Drug Stocks Worth Watching This World Mental Health Day - Zacks Investment Research | 4 CNS Drug Stocks Worth Watching This World Mental Health Day Zacks Investment Research | View source ↗ | Zacks Investment Research | Oct 9, 2026 | neutral | 0 | 0.6 |
| 4 CNS Drug Stocks Worth Watching This World Mental Health Day - Yahoo Finance | 4 CNS Drug Stocks Worth Watching This World Mental Health Day Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Illegal immigrant used DC apartment as 'drug warehouse' to stock fentanyl, cocaine: Pirro - WJLA | Illegal immigrant used DC apartment as 'drug warehouse' to stock fentanyl, cocaine: Pirro WJLA | View source ↗ | WJLA | Oct 8, 2026 | neutral | 0 | 0.6 |
| IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class - Stocktwits | IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class Stocktwits | View source ↗ | Stocktwits | Oct 8, 2026 | neutral | 0 | 0.6 |
| Argenx Stock Sinks on Scrapped Autoimmune Drug Trial. Why the Selloff Is Overdone. - Barron's | Argenx Stock Sinks on Scrapped Autoimmune Drug Trial. Why the Selloff Is Overdone. Barron's | View source ↗ | Barron's | Oct 8, 2026 | neutral | 0 | 0.6 |
| vTv Therapeutics stock jumps on FDA orphan drug status - Yahoo Finance Singapore | vTv Therapeutics stock jumps on FDA orphan drug status Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 8, 2026 | neutral | 0 | 0.6 |
| This Tiny Biotech Stock Is Down 96% This Year. Can Next-Gen Drug Testing Save It? - Barron's | This Tiny Biotech Stock Is Down 96% This Year. Can Next-Gen Drug Testing Save It? Barron's | View source ↗ | Barron's | Oct 7, 2026 | neutral | 0 | 0.6 |
| Zealand's stock slides as Boehringer-partnered obesity drug underwhelms again in phase 3 - Fierce Biotech | Zealand's stock slides as Boehringer-partnered obesity drug underwhelms again in phase 3 Fierce Biotech | View source ↗ | Fierce Biotech | Oct 1, 2026 | neutral | 0 | 0.6 |
| Kodiak Sciences Up 150% At Opening Bell After Drugs Pass Key Trial - Forbes | Kodiak Sciences Up 150% At Opening Bell After Drugs Pass Key Trial Forbes | View source ↗ | Forbes | Sep 28, 2026 | neutral | 0 | 0.6 |
| Kodiak's stock doubles as resurrected eye disease drug matches Eylea in phase 3 - Fierce Biotech | Kodiak's stock doubles as resurrected eye disease drug matches Eylea in phase 3 Fierce Biotech | View source ↗ | Fierce Biotech | Sep 28, 2026 | neutral | 0 | 0.6 |
| We're booking a five-fold profit on one of drug stock's rally to record highs - CNBC | We're booking a five-fold profit on one of drug stock's rally to record highs CNBC | View source ↗ | CNBC | Aug 19, 2026 | neutral | 0 | 0.6 |
| We're booking a five-fold profit on one of drug stock's rally to record highs - CNBC | We're booking a five-fold profit on one of drug stock's rally to record highs CNBC | View source ↗ | CNBC | Aug 19, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.